The N-Site concept was established in conjunction with the BIA and MedCity. The aim is to provide a unique support environment of guidance and expertise for companies and individuals working in Life Sciences.

PharmaVentures and Gallagher will shortly join N-Site to provide a suite of guidance notes on deals and insurance matters respectively.

The N-Site concept was established in conjunction with the BIA and MedCity. The aim is to provide a unique support environment of guidance and expertise for companies and individuals working in Life Sciences.

Combined with the comprehensive tax, investor relations, legal and IP strategy guidance provided by FTI Consulting, Taylor Wessing and Gill Jennings & Every respectively, the platform now has over 95 guidance notes enjoyed by 170 subscribers.

In addition, the following guidance notes have recently been added to N-Site:

Tax Updates

  • Off payroll workers: IR35 for the private sector from April 2020

IP Updates

  • Plausibility Part 1: How much experimental data do you need to include in your patent application?
  • Plausibility Part 2: Can experimental data generated after filing your patent application help secure a granted patent?
  • Special considerations for patenting inventions involving cells or complex biological material

Legal Updates

  • Data and market exclusivity: what it is and how long it lasts
  • IP indemnities in commercial agreements

If you have any feedback or have recommendations for new Guidance Notes or areas of expertise, please contact N-Site.